Biotech

All Articles

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.Operating system Therapies are going to detail on the NYSE American stock substitution this morning...

ALX's waning CD47 reaction price delivers sell spiraling down

.ALX Oncology's phase 2 gastric cancer cells action rate has damaged. After seeing its CD47 blocker ...

Ionis axes eye disease coming from targets of Roche-partnered possibility after records let down

.One More of Ionis Pharmaceuticals' vital midphase readouts has disappointed expectations, cuing the...

Biogen's chief executive officer pointed out no dangerous sell 2023. He prepares to be daring

.While Biogen's pharma peers are actually searching for late-stage properties with little bit of dan...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has actually been a biotech searching for a pipe after it ditched its lead assets over t...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually handed back civil liberties to an early Alzheimer's condition program to Denali...

Takeda touches brand-new mind of US oncology business-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings as well a...

Vertex, hammered through AATD once more, drops 2 resources on throw out stack

.Tip's try to treat a rare hereditary disease has struck another trouble. The biotech shook 2 even m...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Biotechnology's second-quarter earnings report had not been short of major news. The provider a...

Galapagos stops briefly CAR-T tissue treatment litigation over Parkinsonism scenario

.Galapagos has paused application in a test of a BCMA-directed CAR-T tissue treatment, pumping the b...